Skip to main content
. 2022 Sep 23;13:960068. doi: 10.3389/fimmu.2022.960068

Figure 2.

Figure 2

Sanger sequencing validation of the novel variant CFH:c.1841T>C (F614S). The mutation CFH:c.1841T>C (F614S), identified as T/C heterozygote, is marked by an arrow. Illustrative examples for the patients LN21 (A), PI20 (B), and PI22 (C) are shown.